<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04292873</url>
  </required_header>
  <id_info>
    <org_study_id>201902073MIPA</org_study_id>
    <nct_id>NCT04292873</nct_id>
  </id_info>
  <brief_title>Effects of Enteral Supplement Vitamin D Incritically Ill Patients</brief_title>
  <official_title>Investigating the Effects of Enteral Supplement of Vitamin D in Critically Ill Patients With Vitamin D Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      At present, there is no clinical reference data on how much the concentration of calcifediol&#xD;
      in the blood increases after supplementing with vitamin D for Taiwanese ICU patients. This&#xD;
      study aims to investigate the effects of enteral supplementation of vitamin D in critically&#xD;
      ill patients with vitamin D deficiency. The results of the study are expected to provide&#xD;
      clinical reference data to intensivists to select adequate dosage of vitamin D&#xD;
      supplementation for their patients with vitamin D deficiency.&#xD;
&#xD;
      This is a multi-center, randomized clinical trial. ICU patients will receive vitamin D level&#xD;
      examination. If the subject's blood calcifediol concentration is less than 20 ng / mL, the&#xD;
      subject will be included in this clinical trial. Patients who are suitable to enteral&#xD;
      supplement of vitamin D will be randomly divided to group Control (no vitamin D supplement)&#xD;
      and group Vitamin D (enteral supplement of 569,600 IU vitamin D). The vitamin D level will be&#xD;
      measures at specific time points.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D deficiency patients have longer hospital stays, higher medical expenditures, and&#xD;
      higher sepsis-related mortality. The preliminary results of 145 ICU patients of the Northern&#xD;
      Medical Centers in Taiwan in our ongoing multicenter clinical trial showed that the mean&#xD;
      calcifediol concentration was about 20.9 ng/mL, much lower than the normal value of 30-60&#xD;
      ng/ml. An Austrian randomized clinical trial has shown that supplementation of high-dose&#xD;
      vitamin D in critically ill patients with vitamin D deficiency can reduce patient mortality,&#xD;
      so it is important to treat critically ill patients with vitamin D deficiency. At present,&#xD;
      there is no clinical reference data on how much the concentration of calcifediol in the blood&#xD;
      increases after supplementing with vitamin D for Taiwanese ICU patients. This study aims to&#xD;
      investigate the effects of enteral supplementation of vitamin D in critically ill patients&#xD;
      with vitamin D deficiency. The results of the study are expected to provide clinical&#xD;
      reference data to intensivists to select adequate dosage of vitamin D supplementation for&#xD;
      their patients with vitamin D deficiency.&#xD;
&#xD;
      This is a multi-center, randomized clinical trial. ICU patients will receive vitamin D level&#xD;
      examination. If the subject's blood calcifediol concentration is less than 20 ng / mL, the&#xD;
      subject will be included in this clinical trial. Patients who are suitable to enteral&#xD;
      supplement of vitamin D will be randomly divided to group Control (no vitamin D supplement)&#xD;
      and group Vitamin D (enteral supplement of 569,600 IU vitamin D). The vitamin D level will be&#xD;
      measures at specific time points. The patients' diagnosis, vital signs, laboratory data,&#xD;
      30-day survival, and 90-day survival will be recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 16, 2020</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vitmain D level</measure>
    <time_frame>7 days</time_frame>
    <description>blood level of vitamin D</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vitmain D level</measure>
    <time_frame>14 days</time_frame>
    <description>blood level of vitamin D</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Enteral supplement of 569,600 IU vitamin D</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vitamin D supplement</intervention_name>
    <description>Enteral supplement of 569,600 IU vitamin D</description>
    <arm_group_label>Vitamin D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients in intensive care units&#xD;
&#xD;
          -  blood calcifediol concentration less than 20 ng / mL&#xD;
&#xD;
          -  suitable for enteral feeding&#xD;
&#xD;
          -  no ileus, vomit, or diarrhea&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  younger than 20 years old&#xD;
&#xD;
          -  receive high dose vitamin D within 4 weeks (&gt; 3000 IU pre day)&#xD;
&#xD;
          -  hypercalemia ( &gt; 2.6 mmol/L)&#xD;
&#xD;
          -  body weight &lt; 45 or &gt; 90 kg&#xD;
&#xD;
          -  admitted to intensive care unit before this admission within 3 months&#xD;
&#xD;
          -  have diseases as follows: parathyroid disease, rickets, or liver cirrhosis - Child C&#xD;
&#xD;
          -  diagnosed with renal stone, tuberculosis, or sarcoidosis&#xD;
&#xD;
          -  Non-native speaker&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu-Chang Yeh, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu-Chang Yeh, MD, PhD</last_name>
    <phone>+886-910513711</phone>
    <email>tonyyeh@ntuh.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Chang Yeh, MD, PhD</last_name>
      <phone>+886-910513711</phone>
      <email>tonyyeh@ntuh.gov.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 1, 2020</study_first_submitted>
  <study_first_submitted_qc>March 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2020</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin D Deficiency, critical Illness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

